Artemis II and the Importance of Risk Management in Pharmaceutical Quality

The Artemis II mission offers a powerful analogy for how pharmaceutical organizations should approach readiness, risk management, and system reliability. In this episode of The GMP Insider, we explore how NASA's approach to preparation mirrors the principles of strong pharmaceutical Quality systems. Discussion topics include:• Building readiness before critical events occur• Applying risk-based thinking through FMEA and ICH Q9• The importance of validation, simulations, and mock exercises• Cross-functional collaboration across Quality, Manufacturing, Engineering, and Operations• Why disciplined execution matters more than last-minute heroics Just as Artemis II depends on preparation, communication, and risk mitigation, pharmaceutical Quality systems depend on the same disciplined approach to protect patients and ensure reliable performance. Readiness is not built during the moment of crisis — it is built every day before it happens.